Blog

  • Around 70 militants linked to Gul Bahadur group killed in Pakistan’s ‘precision strikes’: Tarar

    Around 70 militants linked to Gul Bahadur group killed in Pakistan’s ‘precision strikes’: Tarar



    A Taliban fighter stands next to vehicles destroyed during an airstrike, following a…

    Continue Reading

  • While shareholders of XP (NASDAQ:XP) are in the red over the last five years, underlying earnings have actually grown

    While shareholders of XP (NASDAQ:XP) are in the red over the last five years, underlying earnings have actually grown

    Generally speaking long term investing is the way to go. But no-one is immune from buying too high. To wit, the XP Inc. (NASDAQ:XP) share price managed to fall 62% over five long years. That is extremely sub-optimal, to say the least. More recently, the share price has dropped a further 17% in a month.

    The recent uptick of 4.7% could be a positive sign of things to come, so let’s take a look at historical fundamentals.

    AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

    While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

    During the unfortunate half decade during which the share price slipped, XP actually saw its earnings per share (EPS) improve by 26% per year. So it doesn’t seem like EPS is a great guide to understanding how the market is valuing the stock. Alternatively, growth expectations may have been unreasonable in the past.

    Because of the sharp contrast between the EPS growth rate and the share price growth, we’re inclined to look to other metrics to understand the changing market sentiment around the stock.

    We note that the dividend has remained healthy, so that wouldn’t really explain the share price drop. While it’s not completely obvious why the share price is down, a closer look at the company’s history might help explain it.

    You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

    NasdaqGS:XP Earnings and Revenue Growth October 18th 2025

    XP is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. Given we have quite a good number of analyst forecasts, it might be well worth checking out this free chart depicting consensus estimates.

    It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It’s fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for XP the TSR over the last 5 years was -58%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the total shareholder return.

    Investors in XP had a tough year, with a total loss of 4.2% (including dividends), against a market gain of about 16%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. However, the loss over the last year isn’t as bad as the 10% per annum loss investors have suffered over the last half decade. We’d need to see some sustained improvements in the key metrics before we could muster much enthusiasm. Importantly, we haven’t analysed XP’s dividend history. This free visual report on its dividends is a must-read if you’re thinking of buying.

    But note: XP may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

    Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Continue Reading

  • 1,800-year-old ancient dragon kiln unearthed in east China

    1,800-year-old ancient dragon kiln unearthed in east China



    1,800-year-old ancient dragon kiln unearthed in east China

    A well-preserved dragon kiln…

    Continue Reading

  • Iran announces official end to 10-year-old nuclear agreement | Iran

    Iran announces official end to 10-year-old nuclear agreement | Iran

    An international deal with Iran designed to keep the world safe from the spread of atomic weapons has officially ended, with Tehran announcing the termination of the decade-old agreement.

    Iran said on Saturday that it was no longer bound by the…

    Continue Reading

  • Iran announces official end to 10-year-old nuclear agreement | Iran

    Iran announces official end to 10-year-old nuclear agreement | Iran

    An international deal with Iran designed to keep the world safe from the spread of atomic weapons has officially ended, with Tehran announcing the termination of the decade-old agreement.

    Iran said on Saturday that it was no longer bound by the…

    Continue Reading

  • Unlock true multiomics with Semi-Permeable Capsules

    Unlock true multiomics with Semi-Permeable Capsules

    Atrandi Biosciences is changing how scientists explore cells with its proprietary Semi-Permeable Capsule (SPC) technology. SPCs isolate single cells in permeable compartments, enabling high-throughput, multi-step workflows while maintaining…

    Continue Reading

  • Recreational topographic USGS maps are now free to download

    Recreational topographic USGS maps are now free to download

    You can now get detailed topographic maps that put trails, rivers, and campgrounds front and center without paying a dime.

    The new 25K Recreational Topo series is built for people who plan trips on foot, bike, or boat and want reliable detail…

    Continue Reading

  • Male Brains Shrink Faster Than Female Brains, Study Finds : ScienceAlert

    Male Brains Shrink Faster Than Female Brains, Study Finds : ScienceAlert

    New evidence has found that male brains really may shrink faster than female brains with age.

    Among 4,726 participants with healthy cognition, brain scans have revealed “modest yet systematic sex differences” in how neurological tissue wastes…

    Continue Reading

  • Just a moment…

    Just a moment…

    Continue Reading